Marinus signs government contract worth up to $51M to advance drug candidate

The contract will support preclinical studies of the company's new drug candidate against nerve agents.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.